Teleflex traded at $134.05 this Monday July 20th, decreasing $0.56 or 0.42 percent since the previous trading session. Looking back, over the last four weeks, Teleflex lost 5.55 percent. Over the last 12 months, its price rose by 20.70 percent. Looking ahead, we forecast Teleflex to be priced at 132.99 by the end of this quarter and at 124.78 in one year, according to Trading Economics global macro models projections and analysts expectations.
Teleflex Incorporated is a provider of medical technology products. The Company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through four segments: Americas; Europe, Middle East and Africa (EMEA); Asia (Asia Pacific), and Original Equipment Manufacturer and Development Services (OEM). Its product categories include vascular access, anesthesia, interventional, surgical, interventional urology, and urology. The Company's specialty product line of urology products provides bladder management. The product portfolio consists of a range of catheters, including Foley, intermittent, external and suprapubic; urine collectors; catheterization accessories, and products for operative endourology marketed under the Rusch brand name.